PHI with Nephroangiosclerosis
How does this condition affect your private health insurance?
Nephroangiosclerosis, also known as hypertensive nephrosclerosis, is a chronic kidney disease resulting from long-standing, uncontrolled high blood pressure. It involves the hardening and narrowing of small blood vessels within the kidneys, impairing their ability to filter waste products from the blood effectively. This damage leads to reduced kidney function, often initially asymptomatic, but progressively manifests as proteinuria, elevated creatinine levels, and eventually chronic kidney disease. Without proper blood pressure management, it can advance to end-stage renal disease, necessitating dialysis or kidney transplantation. It's a significant cause of kidney failure globally, particularly in older adults with persistent hypertension.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Often asymptomatic for years, gradual onset of kidney function decline detected via routine tests; initial symptoms, if any, are typically non-specific.
Duration of Illness (Lifetime)
Chronic, progressive, lifelong condition requiring continuous management of blood pressure and kidney function.
Cost of Treatment (Initial)
Initial diagnostic costs (blood tests, urinalysis, imaging) typically range from a few hundred to several thousand USD, depending on the healthcare system and extent of initial workup.
Cost of Treatment (Lifetime)
Can be very high, ranging from tens of thousands to hundreds of thousands of USD over a lifetime, especially if it progresses to end-stage renal disease requiring lifelong dialysis or kidney transplantation and associated medications.
Mortality Rate
Significantly increased risk of cardiovascular events (heart attack, stroke) and progression to end-stage renal disease, leading to a higher mortality rate compared to the general population, particularly without effective blood pressure control.
Risk of Secondary Damages
High. Includes progressive chronic kidney disease, end-stage renal disease, cardiovascular diseases (heart attack, stroke), retinopathy (eye damage), and peripheral artery disease.
Probability of Full Recovery
Low to negligible. Damage to kidney microvasculature is largely irreversible; treatment focuses on slowing progression, preventing further damage, and managing complications rather than achieving full recovery.
Underlying Disease Risk
High. Primarily associated with essential hypertension (very high probability); also frequently linked to diabetes, hyperlipidemia, and other cardiovascular risk factors.